These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1198423)

  • 21. An in vitro method for platelet morphological studies employing a reconstituted collagen substrate.
    Albert EN; Daniel RE; Whiting JD; Bailey JM
    Scan Electron Microsc; 1979; (3):131-8. PubMed ID: 392702
    [No Abstract]   [Full Text] [Related]  

  • 22. Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
    Hanson SR; Harker LA
    Ann N Y Acad Sci; 1983; 416():642-50. PubMed ID: 6587821
    [No Abstract]   [Full Text] [Related]  

  • 23. [Indications and uncertainties of antiaggregating agents].
    Verstraete M
    Rev Prat; 1977 Dec; 27(57):3999-4005. PubMed ID: 345400
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of platelets in thrombotic and vascular disease.
    Schafer AI; Handin RI
    Prog Cardiovasc Dis; 1979; 22(1):31-52. PubMed ID: 379914
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings: Response of normal and pathological platelets to heparin added in vitrio and in vivo.
    David JL; Herion FP
    Thromb Diath Haemorrh; 1975 Sep; 34(1):341. PubMed ID: 1188778
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
    Baumgartner HR
    Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of action of currently used antiplatelet drugs.
    de Gaetano G; Bertele' V; Cerletti C
    Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs in the treatment of thrombo-embolic disease--part I.
    Bouchier-Hayes D
    Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of platelet aggregation inhibitors on platelet damage at prosthetic heart valves in-vitro (author's transl)].
    Häussinger G; Pfennigs H; Chelapurath A; Reul H; Essers U
    Biomed Tech (Berl); 1981 May; 26(5):99-102. PubMed ID: 6788103
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: The effect of sulphinpyrazone (Anturan) on immunologically derived thrombocytopenia and on platelet survival.
    White AM; Butler KD
    Thromb Diath Haemorrh; 1975 Nov; 34(2):553-4. PubMed ID: 128152
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo.
    Groves HM; Kinlough-Rathbone RL; Cazenave JP; Dejana E; Richardson M; Mustard JF
    J Lab Clin Med; 1982 Apr; 99(4):548-58. PubMed ID: 7038012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The retired breeder rat as a new model for antiplatelet drug discovery.
    Saunders RN; Burns TS; Stelzer MR; Waskawic ER
    Lab Anim Sci; 1977 Oct; 27(5 Pt 2):757-61. PubMed ID: 592727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood platelet function in patients treated with verapamil. Comparison with dipyridamole and acetyl salicylic acid].
    Martínez-Brotons F; Portis T; Simón R; Pérez-Ayuso MJ; Kian C; Reynaldo C; Gausí C
    Med Clin (Barc); 1987 Jun; 89(3):104-7. PubMed ID: 3626647
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Binding of (14C) dipyradamole (RA 8) to platelets and inhibition of ADP induced platelet aggregation.
    Subbarao K; Rucinski B; Niewarowski S
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552-3. PubMed ID: 1198424
    [No Abstract]   [Full Text] [Related]  

  • 37. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
    McCollum CN; Crow MJ; Rajah SM; Kester RC
    Surgery; 1980 Jun; 87(6):668-76. PubMed ID: 6445604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment and prevention of thromboembolism with anti-aggregation drugs].
    Donner L
    Vnitr Lek; 1981 May; 27(5):487-95. PubMed ID: 7245635
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
    Weiss HJ
    Am Heart J; 1976 Jul; 92(1):86-102. PubMed ID: 785989
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; García Arnés J; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1986 May; 86(17):712-5. PubMed ID: 3736161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.